This research highlights the need to select patients with a history of Crohn’s Disease or ulcerative colitis to be screened for this condition before they begin treatment with chemotherapy.
Johns Hopkins University School of Medicine, Baltimore, MD; The Oregon Clinic, Gastroenterology East, Portland, OR; MedStar Georgetown University Hospital, Washington, DC; Sutter Health, Palo Alto, CA; Saratoga Schenectady Gastroenterology Associates, Burnt Hills, NY; H. H. Chao Comprehensive Digestive Disease Center, University of California Irvine, Orange, CA; Center for Crohn’s Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates, Atlanta, GA; Gastro One, Germantown, TN; Stony Brook University Hospital, East Setauket, NY; Attune Health, Los Angeles, CA; Cedars-Sinai Medical Center, Beverly Hills, CA; University of Mississippi Medical Center, Jackson, MS; Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, CA; Cedars-Sinai Medical Group, Los Angeles, CA.